Sign in
4

Changes in Ownership

Benitec Biopharma Inc. Filed Acc 0001062993-20-006255

Options or other derivatives

  • Executive Director acquired 142,172 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Boston Megan Executive Director 2020-12-09 Grant or award · Options (right to buy) +142,172 142,172 D
Loading xslF345X03/form4.xml…